Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Michelle Gilson is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/03/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 01/09/2025 | VIR | Buy Now | Vir Biotechnology | $5.77 | 246.62% | Michelle Gilson40% | $10 → $20 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 06/06/2024 | VIR | Buy Now | Vir Biotechnology | $5.77 | 159.97% | Michelle Gilson40% | $12 → $15 | Maintains | Equal-Weight | Get Alert |
| 07/21/2023 | VIR | Buy Now | Vir Biotechnology | $5.77 | 159.97% | Michelle Gilson40% | $27 → $15 | Maintains | Equal-Weight | Get Alert |
| 04/04/2023 | VIR | Buy Now | Vir Biotechnology | $5.77 | 367.94% | Michelle Gilson40% | $25 → $27 | Maintains | Equal-Weight | Get Alert |
| 04/06/2022 | FIXX | Buy Now | Homology Medicines | — | — | Michelle Gilson40% | $342 → $126 | Maintains | Buy | Get Alert |
| 02/02/2022 | CORT | Buy Now | Corcept Therapeutics | $75.91 | -60.48% | Michelle Gilson40% | → $30 | Initiates | → Buy | Get Alert |
| 12/23/2021 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Michelle Gilson40% | $156 → $91 | Maintains | Buy | Get Alert |
| 11/29/2021 | RZLT | Buy Now | Rezolute | $2.62 | 548.85% | Michelle Gilson40% | $30 → $17 | Maintains | Buy | Get Alert |
| 07/19/2021 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Michelle Gilson40% | $806 → $559 | Maintains | Buy | Get Alert |
| 06/01/2021 | ASND | Buy Now | Ascendis Pharma | $150.09 | 30.59% | Michelle Gilson40% | $190 → $196 | Maintains | Buy | Get Alert |
| 05/27/2021 | TVTX | Buy Now | Travere Therapeutics | $15.37 | 192.78% | Michelle Gilson40% | $48 → $45 | Maintains | Buy | Get Alert |
| 05/17/2021 | TVTX | Buy Now | Travere Therapeutics | $15.37 | 212.3% | Michelle Gilson40% | $51 → $48 | Maintains | Buy | Get Alert |
| 05/12/2021 | RZLT | Buy Now | Rezolute | $2.62 | 1045.04% | Michelle Gilson40% | $33 → $30 | Maintains | Buy | Get Alert |
| 03/12/2021 | ASND | Buy Now | Ascendis Pharma | $150.09 | 26.59% | Michelle Gilson40% | $172 → $190 | Maintains | Buy | Get Alert |
| 03/11/2021 | STOK | Buy Now | Stoke Therapeutics | $6.04 | 1159.32% | Michelle Gilson40% | $72 → $76 | Maintains | Buy | Get Alert |
| 03/01/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | 39.36% | Michelle Gilson40% | $95 → $91 | Maintains | Buy | Get Alert |
| 02/03/2021 | TVTX | Buy Now | Travere Therapeutics | $15.37 | 231.82% | Michelle Gilson40% | $28 → $51 | Maintains | Buy | Get Alert |
| 01/08/2021 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Michelle Gilson40% | → $806 | Initiates | → Buy | Get Alert |
| 12/28/2020 | STOK | Buy Now | Stoke Therapeutics | $6.04 | 1093.04% | Michelle Gilson40% | $53 → $72 | Maintains | Buy | Get Alert |
| 11/13/2020 | STOK | Buy Now | Stoke Therapeutics | $6.04 | 778.21% | Michelle Gilson40% | $49 → $53 | Maintains | Buy | Get Alert |
| 08/20/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | 45.48% | Michelle Gilson40% | $119 → $95 | Maintains | Buy | Get Alert |
| 07/20/2020 | AMYT | Buy Now | Amryt Pharma | — | — | Michelle Gilson40% | → $40 | Initiates | → Buy | Get Alert |
| 10/28/2019 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | 65.39% | Michelle Gilson40% | $117 → $108 | Maintains | Buy | Get Alert |
| 08/23/2019 | RTRX | Buy Now | Retrophin | — | — | Michelle Gilson40% | $38 → $23 | Maintains | Buy | Get Alert |
| 07/15/2019 | STOK | Buy Now | Stoke Therapeutics | $6.04 | 629.08% | Michelle Gilson40% | → $44 | Initiates | → Buy | Get Alert |
| 05/31/2019 | ASND | Buy Now | Ascendis Pharma | $150.09 | -4.06% | Michelle Gilson40% | $133 → $144 | Maintains | Buy | Get Alert |
| 04/05/2019 | ASND | Buy Now | Ascendis Pharma | $150.09 | -11.39% | Michelle Gilson40% | $132 → $133 | Maintains | Buy | Get Alert |
| 01/07/2019 | FIXX | Buy Now | Homology Medicines | — | — | Michelle Gilson40% | → $666 | Initiates | → Buy | Get Alert |
| 10/23/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | 77.64% | Michelle Gilson40% | $113 → $116 | Maintains | Buy | Get Alert |
| 08/17/2018 | RTRX | Buy Now | Retrophin | — | — | Michelle Gilson40% | → $36 | Initiates | → Buy | Get Alert |
| 08/07/2018 | ASND | Buy Now | Ascendis Pharma | $150.09 | -46.03% | Michelle Gilson40% | → $81 | Initiates | → Buy | Get Alert |
| 07/31/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | 73.05% | Michelle Gilson40% | $105 → $113 | Maintains | Buy | Get Alert |
| 05/25/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | 60.8% | Michelle Gilson40% | $101 → $105 | Maintains | Buy | Get Alert |
| 05/16/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | 54.67% | Michelle Gilson40% | → $101 | Initiates | → Buy | Get Alert |
| 06/18/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | 129.71% | Michelle Gilson40% | $115 → $150 | Maintains | Buy | Get Alert |
| 09/05/2013 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | 30.17% | Michelle Gilson40% | $71 → $85 | Maintains | Buy | Get Alert |
| 02/12/2013 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | 8.73% | Michelle Gilson40% | $56 → $71 | Maintains | Buy | Get Alert |
| 11/05/2012 | BMRN | Buy Now | Biomarin Pharmaceutical | $65.30 | -14.24% | Michelle Gilson40% | $52 → $56 | Maintains | Buy | Get Alert |
| 03/26/2012 | BMRN | Buy Now | BioMarin Pharmaceuticals | $65.30 | -34.15% | Michelle Gilson40% | → $43 | Initiates | → Buy | Get Alert |
